Weaver C. Barksdale & Associates’s Trustmark TRMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$3K Buy
109
+3
+3% +$99 ﹤0.01% 431
2017
Q3
$4K Buy
106
+12
+13% +$373 ﹤0.01% 398
2017
Q2
$3K Sell
94
-14
-13% -$449 ﹤0.01% 448
2017
Q1
$3K Buy
108
+20
+23% +$663 ﹤0.01% 459
2016
Q4
$3K Sell
88
-10
-10% -$314 ﹤0.01% 454
2016
Q3
$3K Hold
98
0.01% 448
2016
Q2
$2K Hold
98
﹤0.01% 473
2016
Q1
$2K Hold
98
﹤0.01% 494
2015
Q4
$2K Sell
98
-6
-6% -$145 ﹤0.01% 489
2015
Q3
$2K Sell
104
-8
-7% -$190 ﹤0.01% 489
2015
Q2
$3K Hold
112
﹤0.01% 468
2015
Q1
$3K Hold
112
﹤0.01% 469
2014
Q4
$3K Hold
112
﹤0.01% 459
2014
Q3
$3K Hold
112
﹤0.01% 449
2014
Q2
$3K Buy
112
+10
+10% +$238 ﹤0.01% 469
2014
Q1
$3K Buy
102
+11
+12% +$273 ﹤0.01% 462
2013
Q4
$2K Hold
91
﹤0.01% 512
2013
Q3
$2K Hold
91
﹤0.01% 518
2013
Q2
$2K Buy
+91
New +$2.24K ﹤0.01% 503

Other funds holding TRMK

Weaver C. Barksdale & Associates's TRMK Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its Trustmark (TRMK) stake by 2.8% in Q4 2017, buying an estimated $99 and bringing the position to 109 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #431.

Weaver C. Barksdale & Associates first reported a position in TRMK in Q2 2013 and has held it in 19 quarters since. The position peaked at $4K in Q3 2017. 201 funds tracked by Wall St. Rank hold TRMK as of Q4 2017.

  • Weaver C. Barksdale & Associates held 109 shares of Trustmark worth $3K as of Q4 2017.
  • Weaver C. Barksdale & Associates bought 3 Trustmark shares in Q4 2017, an estimated $99.
  • Trustmark made up ﹤0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #431 holding.
  • Weaver C. Barksdale & Associates first reported a position in Trustmark in Q2 2013 and has held it in 19 quarters since.
  • Weaver C. Barksdale & Associates's Trustmark position peaked at $4K in Q3 2017.
  • 201 funds tracked by Wall St. Rank held Trustmark as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.